387510622	387510622	CD	B-NP	O
|	|	NN	I-NP	O
LVSMH	LVSMH	NN	I-NP	O
|	|	NN	I-NP	O
15861687	15861687	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5394984	5394984	CD	B-NP	O
|	|	CC	I-NP	O
9/16/2006	9/16/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
transaminitis	transaminitis	NN	I-NP	O
,	,	,	O	O
CBD	CBD	NN	B-NP	O
dilitation	dilitation	NN	I-NP	O
,	,	,	O	O
pancreatic	pancreatic	JJ	B-NP	O
duct	duct	NN	I-NP	O
dilitation	dilitation	NN	I-NP	O
s/p	s/p	NN	I-NP	O
stenting	stenting	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
sphinterectomy	sphinterectomy	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/30/2006	3/30/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/2/2006	2/2/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
FLEITMAN	FLEITMAN	NNP	B-NP	O
,	,	,	O	O
BENNETT	BENNETT	NNP	B-NP	O
V	V	NNP	I-NP	O
373-63-33-4	373-63-33-4	CD	I-NP	O
V10	V10	NNP	I-NP	O
Room	Room	NNP	I-NP	O
:	:	:	O	O
Te	Te	NNP	B-NP	O
Tarage	Tarage	NNP	I-NP	O
A	A	NNP	I-NP	O
Cam	Cam	NNP	I-NP	O
Seymasa	Seymasa	NNP	I-NP	O
,	,	,	O	O
Indiana	Indiana	NNP	B-NP	O
06498	06498	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
1/18/06	1/18/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CAFARO	CAFARO	NNP	B-NP	O
,	,	,	O	O
ADALBERTO	ADALBERTO	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BABY	BABY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERI	ENTERI	NNP	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	NNP	B-NP	O
162	162	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/18/06	1/18/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
ELEMENTAL	ELEMENTAL	NN	I-NP	O
CA	CA	NN	I-NP	O
+	+	SYM	B-VP	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	O	O
500	500	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
HUMAN	HUMAN	NN	I-NP	B-DNA
20	20	CD	B-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
AVAPRO	AVAPRO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IRBESARTAN	IRBESARTAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
150	150	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/6/06	7/6/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
IRBESARTAN	IRBESARTAN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
IRBESARTAN	IRBESARTAN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/6/06	7/6/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
IRBESARTAN	IRBESARTAN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
IRBESARTAN	IRBESARTAN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/30/06	10/30/06	CD	B-NP	O
by	by	IN	B-PP	O
ENCE	ENCE	NNP	B-NP	O
,	,	,	O	O
TY	TY	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
IRBESARTAN	IRBESARTAN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
IRBESARTAN	IRBESARTAN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
reason	reason	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/30/06	10/30/06	CD	B-NP	O
by	by	IN	B-PP	O
ELWONGER	ELWONGER	NNP	B-NP	O
,	,	,	O	O
JOHNNY	JOHNNY	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
665886938	665886938	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
IRBESARTAN	IRBESARTAN	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/30/06	10/30/06	CD	B-NP	O
by	by	IN	B-PP	O
RUBIANO	RUBIANO	NNP	B-NP	O
,	,	,	O	O
NUMBERS	NUMBERS	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
765178698	765178698	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
IRBESARTAN	IRBESARTAN	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
LEVAQUIN	LEVAQUIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
500	500	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q48H	Q48H	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

LOPRESSOR	LOPRESSOR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/24	10/24	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
HR	HR	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
OR	OR	NN	I-NP	O
SBP	SBP	NN	I-NP	O
<	<	SYM	O	O
110	110	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

PILOCARPINE	PILOCARPINE	NN	B-NP	B-protein
0.5	0.5	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
DROP	DROP	NNP	I-NP	I-protein
OS	OS	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
10/24	10/24	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NN	I-NP	I-protein
MULTIVI	MULTIVI	NN	I-NP	I-protein
...	...	:	O	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
VITAMIN	VITAMIN	NNP	I-NP	O
E	E	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TOCOPHEROL-DL-ALPHA	TOCOPHEROL-DL-ALPHA	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
400	400	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ALPHAGAN	ALPHAGAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BRIMONIDINE	BRIMONIDINE	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
DROP	DROP	NN	I-NP	O
OU	OU	NN	I-NP	O
BID	BID	NN	I-NP	O
XALATAN	XALATAN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LATANOPROST	LATANOPROST	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
DROP	DROP	NN	I-NP	O
OU	OU	NN	I-NP	O
QPM	QPM	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
PCP	PCP	NN	B-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
on	on	IN	B-PP	O
4/11	4/11	CD	B-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
,	,	,	O	O
Stent	Stent	NNP	B-NP	O
removal	removal	NN	I-NP	O
Dr	Dr	NNP	I-NP	O
Menietto	Menietto	NNP	I-NP	O
7/20	7/20	CD	I-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
endoscopy	endoscopy	NN	I-NP	O
,	,	,	O	O
GI	GI	NNP	B-NP	O
Dr	Dr	NNP	I-NP	O
Scroggin	Scroggin	NNP	I-NP	O
8/10	8/10	CD	I-NP	O
9am	9am	CD	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
transaminitis	transaminitis	NN	I-NP	O
,	,	,	O	O
CBD	CBD	NN	B-NP	O
dilitation	dilitation	NN	I-NP	O
,	,	,	O	O
pancreatic	pancreatic	JJ	B-NP	O
duct	duct	NN	I-NP	O
dilitation	dilitation	NN	I-NP	O
s/p	s/p	NN	I-NP	O
stenting	stenting	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
sphinterectomy	sphinterectomy	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
DM	DM	NNP	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Esophageal	Esophageal	NNP	B-NP	O
Ca	Ca	NNP	I-NP	O
,	,	,	O	O
glaucoma	glaucoma	NN	B-NP	O
,	,	,	O	O
PPM	PPM	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
ercp	ercp	NN	I-NP	O
stenting	stenting	NN	I-NP	O
and	and	CC	I-NP	O
sphinterotomy	sphinterotomy	NN	I-NP	O
on	on	IN	B-PP	O
9/17/06	9/17/06	CD	B-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Abd	Abd	NN	B-NP	O
Pain	Pain	NN	I-NP	O
/	/	SYM	B-NP	O
GNR	GNR	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
***	***	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
88F	88F	NN	B-NP	O
w	w	NN	I-NP	O
DM	DM	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
PPM	PPM	NNP	I-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	B-protein
esoph	esoph	NN	I-NP	I-protein
CA	CA	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
resxn	resxn	NN	I-NP	I-protein
p/w	p/w	NN	I-NP	I-protein
acute	acute	JJ	I-NP	I-protein
onset	onset	NN	I-NP	I-protein
diffuse	diffuse	JJ	I-NP	I-protein
abd	abd	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
somewhat	somewhat	RB	B-ADJP	O
stronger	strong	JJR	I-ADJP	O
in	in	IN	B-PP	O
LLQ	LLQ	NN	B-NP	B-protein
,	,	,	O	O
sharp	sharp	JJ	B-NP	O
,	,	,	I-NP	O
a/w	a/w	JJ	I-NP	O
nausea	nausea	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NNP	B-NP	O
worse	worse	VBP	B-VP	O
with	with	IN	B-PP	O
eating	eat	VBG	B-NP	O
.	.	.	O	O

Had	Have	VBD	B-VP	O
loose	loose	JJ	B-NP	O
BMs	BM	NNS	I-NP	O
x	x	SYM	B-NP	O
3-4	3-4	CD	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
chills	chill	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
,	,	,	O	O
no	no	DT	B-NP	O
palps	palp	NNS	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
stable	stable	JJ	I-NP	O
DOE	DOE	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NNP	B-NP	O
,	,	,	O	O
Abd	Abd	NNP	B-NP	O
CT	CT	NNP	I-NP	O
,	,	,	O	O
U/S	U/S	NNP	B-NP	O
,	,	,	O	O
HIDA	HIDA	NNP	B-NP	O
scan	scan	VBP	B-VP	O
all	all	DT	B-NP	O
unremarkble	unremarkble	JJ	I-NP	O
,	,	,	O	O
but	but	CC	O	O
2/4	2/4	CD	B-NP	O
BCx	BCx	NN	I-NP	O
with	with	IN	B-PP	O
GNRs	GNR	NNS	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Levo/Flagyl	Levo/Flagyl	NNP	B-NP	O
.	.	.	O	O

***	***	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
TIA/CVA	TIA/CVA	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
esoph	esoph	NN	I-NP	O
CA	CA	NN	I-NP	O
s/p	s/p	NN	I-NP	O
resection	resection	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
PPM	PPM	NN	I-NP	O
***	***	SYM	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	B-protein
***	***	SYM	I-NP	O
HOME	HOME	NN	I-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
Lipitor	Lipitor	NN	B-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
Vit	Vit	NNP	B-NP	O
E	E	NNP	I-NP	O
400	400	CD	I-NP	O
,	,	,	O	O
Pilocarpine	Pilocarpine	NNP	B-NP	O
,	,	,	O	O
Timolol	Timolol	NNP	B-NP	O
,	,	,	O	O
Insulin	Insulin	NNP	B-NP	O
70/30	70/30	CD	I-NP	O
20	20	CD	I-NP	O
QAM	QAM	NN	I-NP	O
,	,	,	O	O
HCTZ	HCTZ	NN	B-NP	B-DNA
25	25	CD	I-NP	I-DNA
,	,	,	O	O
PPI	PPI	NNP	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
50	50	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
Avapro	Avapro	NNP	B-NP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
***	***	NNP	I-NP	O
PEx	PEx	NNP	I-NP	O
:	:	:	O	O
T96	T96	NN	B-NP	O
.9	.9	CD	B-NP	O
P56	P56	NN	I-NP	O
140/46	140/46	CD	B-NP	O
Sats	Sat	NNS	I-NP	O
ok	ok	VBP	B-VP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
.	.	.	O	O

NAD	NAD	NN	B-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
clear	clear	JJ	B-ADJP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
S1/S2	S1/S2	NN	I-NP	I-protein
.	.	.	O	O

Abd	Abd	NN	B-NP	O
S/ND	S/ND	NN	I-NP	O
.	.	.	O	O

Very	Very	JJ	B-NP	O
mild	mild	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
somewhat	somewhat	RB	B-VP	O
localized	localize	VBN	I-VP	O
over	over	IN	B-PP	O
LLQ	LLQ	NN	B-NP	B-protein
.	.	.	O	O

Hyperactive	Hyperactive	JJ	B-NP	O
BS	BS	NN	I-NP	O
.	.	.	O	O

Ext	Ext	NNP	B-NP	O
WWP	WWP	NNP	I-NP	O
.	.	.	O	O

NONTOXIC	NONTOXIC	NN	B-NP	O
looking	looking	NN	I-NP	O
.	.	.	O	O

***	***	SYM	B-NP	O
STUDIES	STUDIES	NN	I-NP	O
:	:	:	O	O
Abd	Abd	NN	B-NP	O
CT	CT	NN	I-NP	O
:	:	:	O	O
GB	GB	NN	B-NP	O
wall	wall	NN	I-NP	O
thickening	thickening	NN	I-NP	O
,	,	,	O	O
dilatation	dilatation	NN	B-NP	O
of	of	IN	B-PP	O
pancreatic	pancreatic	JJ	B-NP	O
duct	duct	NN	I-NP	O
.	.	.	O	O

HIDA	HIDA	NN	B-NP	B-protein
:	:	:	O	O
neg	neg	NN	B-NP	O
for	for	IN	B-PP	O
CBD	CBD	NN	B-NP	O
dist	dist	NN	I-NP	O
RUQ	RUQ	NN	I-NP	O
U/S	U/S	NN	I-NP	O
:	:	:	O	O
GB	GB	NN	B-NP	B-protein
sludge	sludge	NN	I-NP	I-protein
***	***	SYM	B-NP	I-protein
NOTABLE	NOTABLE	NN	I-NP	I-protein
LABS	LABS	NN	I-NP	I-protein
:	:	:	O	O
AST	AST	NN	B-NP	O
1425	1425	CD	I-NP	O
,	,	,	O	O
ALT	ALT	NN	B-NP	O
1259	1259	CD	I-NP	O
,	,	,	O	O
AlkPhos	AlkPhos	NNP	B-NP	O
198	198	CD	I-NP	O
,	,	,	O	O
TB	TB	NN	B-NP	B-protein
1.9	1.9	CD	I-NP	I-protein
,	,	,	O	O
Amy	Amy	NNP	B-NP	O
90	90	CD	I-NP	O
.	.	.	O	O

Chem	Chem	NNP	B-NP	O
7	7	CD	I-NP	O
/	/	SYM	B-NP	O
CBC	CBC	NN	I-NP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
anion	anion	NN	I-NP	O
gap	gap	NN	I-NP	O
.	.	.	O	O

BCx	BCx	NN	B-NP	B-protein
with	with	IN	B-PP	O
2/4	2/4	CD	B-NP	O
GNRs	GNR	NNS	I-NP	O
.	.	.	O	O

***	***	SYM	B-NP	O
A/P	A/P	NN	I-NP	O
:	:	:	O	O
88F	88F	NN	B-NP	O
w	w	NN	I-NP	O
abd	abd	NN	I-NP	O
pain	pain	NN	I-NP	O
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
transaminitis	transaminitis	NN	B-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
suspected	suspect	VBN	B-NP	O
bile	bile	NN	I-NP	O
duct	duct	NN	I-NP	O
stones	stone	NNS	I-NP	O
and	and	CC	O	O
sludge	sludge	NN	B-NP	O
.	.	.	O	O

Underwent	Underwent	JJ	B-NP	O
ERCP	ERCP	NN	I-NP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
dilated	dilate	VBN	I-VP	O
main	main	JJ	B-NP	O
pancreatitic	pancreatitic	JJ	I-NP	O
duct	duct	NN	I-NP	O
s/p	s/p	NN	I-NP	O
stenting	stente	VBG	B-VP	O
,	,	,	O	O
dilated	dilated	JJ	B-NP	O
CBD	CBD	NN	I-NP	O
with	with	IN	B-PP	O
sludge	sludge	NN	B-NP	O
s/p	s/p	NN	I-NP	O
sphinterectomy	sphinterectomy	NN	I-NP	O
.	.	.	O	O

Transaminitis	Transaminitis	NN	B-NP	O
and	and	CC	I-NP	O
abd	abd	NN	I-NP	O
pain	pain	NN	I-NP	O
have	have	VBP	B-VP	O
continued	continue	VBN	I-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
.	.	.	O	O

***	***	SYM	B-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
Given	Give	VBN	B-NP	O
GNR	GNR	NN	I-NP	O
bacteremia	bacteremia	NN	I-NP	O
,	,	,	O	O
emperically	emperically	RB	B-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
Levo	Levo	NN	B-NP	B-protein
/	/	SYM	I-NP	I-protein
Ceftaz	Ceftaz	NN	I-NP	I-protein
.	.	.	O	O

Cx	Cx	NN	B-NP	B-protein
grew	grow	VBD	B-VP	I-protein
pansensitive	pansensitive	JJ	B-NP	I-protein
Kleb	Kleb	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
coverage	coverage	NN	B-NP	O
was	be	VBD	B-VP	O
narrowed	narrow	VBN	I-VP	O
to	to	TO	B-PP	O
Levo	Levo	NNP	B-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
14	14	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Surveillance	Surveillance	NN	B-NP	O
cx	cx	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Marked	Marked	JJ	B-NP	O
transaminitis	transaminitis	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
recent	recent	JJ	I-NP	O
new	new	JJ	I-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

Hepatitis	Hepatitis	NN	B-NP	O
serologies	serology	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
U/S	U/S	NNP	B-NP	O
w	w	NNP	I-NP	O
Doppler	Doppler	NNP	I-NP	O
to	to	TO	B-VP	O
r/o	r/o	VB	I-VP	O
Budd-Chiari	Budd-Chiari	NNP	B-NP	O
esp	esp	VB	B-VP	O
given	give	VBN	I-VP	O
acute	acute	JJ	B-NP	O
onset	onset	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
Lactate	Lactate	NN	B-NP	O
+	+	SYM	B-NP	O
guaiac	guaiac	NN	I-NP	O
for	for	IN	B-PP	O
?	?	.	O	O

mesenteric	mesenteric	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
gap	gap	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
indication	indication	NN	I-NP	O
for	for	IN	B-PP	O
surgery	surgery	NN	B-NP	O
.	.	.	O	O

GI	GI	NN	B-NP	O
consulted	consult	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
ERC	ERC	NNP	B-NP	O
,	,	,	O	O
results	result	VBZ	B-VP	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
trending	trend	VBG	B-VP	O
down	down	RP	B-PRT	O
s/p	s/p	NN	B-NP	O
sphinterotomy	sphinterotomy	NN	I-NP	O
and	and	CC	O	O
ERCP	ERCP	NN	B-NP	B-protein
.	.	.	O	O

Will	Will	MD	O	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
GI	GI	NN	B-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
for	for	IN	B-PP	O
repeat	repeat	NN	B-NP	O
ERCP	ERCP	NN	I-NP	O
at	at	IN	B-PP	O
OEDMC	OEDMC	NN	B-NP	B-protein
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Cont	Cont	NNP	B-NP	O
Lipitor	Lipitor	NNP	I-NP	O
,	,	,	O	O
HCTZ	HCTZ	NNP	B-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
,	,	,	O	O
Avapro	Avapro	NNP	B-NP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
failure	failure	NN	B-NP	O
.	.	.	O	O

Uptitrated	Uptitrate	VBN	B-VP	O
avapro	avapro	RB	I-VP	O
given	give	VBN	I-VP	O
persistent	persistent	JJ	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
appears	appear	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
near	near	IN	B-PP	O
maximally	maximally	RB	B-NP	O
BB	BB	NNP	I-NP	O
in	in	IN	B-PP	O
terms	term	NNS	B-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
OPHTH	OPHTH	NN	I-NP	O
:	:	:	O	O
Cont	Cont	JJ	B-NP	O
eye	eye	NN	I-NP	O
drops	drop	VBZ	B-VP	O
ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
h/o	h/o	NN	B-NP	O
DM	DM	NNP	I-NP	O
,	,	,	O	O
cont	cont	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
+	+	SYM	B-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

FEN	FEN	NNP	B-NP	O
:	:	:	O	O
Npo	Npo	NNP	B-NP	B-protein
pending	pende	VBG	B-PP	O
ercp	ercp	NN	B-NP	O
,	,	,	O	O
adv	adv	NN	B-NP	O
to	to	TO	B-PP	O
clears	clear	NNS	B-NP	O
s/p	s/p	NN	I-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-VP	O
tolerated	tolerate	VBN	I-VP	O
,	,	,	O	O
K/Mg	K/Mg	NN	B-NP	O
scales	scale	NNS	I-NP	O
.	.	.	O	O

Ppx	Ppx	NN	B-NP	B-protein
:	:	:	O	O
Nexium	Nexium	NN	B-NP	O
/	/	SYM	B-NP	O
Lovenox	Lovenox	NN	I-NP	O
Full	Full	NNP	I-NP	O
Code	Code	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNP	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
f/u	f/u	NN	I-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
and	and	CC	I-NP	O
Gi	Gi	NN	I-NP	O
as	as	IN	B-PP	O
scheduled	scheduled	JJ	B-NP	O
*	*	SYM	I-NP	O
return	return	NN	I-NP	O
to	to	TO	B-VP	O
ED	ED	VBN	I-VP	O
with	with	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
abd	abd	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	O	O
if	if	IN	B-SBAR	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolera	tolera	VB	I-VP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SALEH	SALEH	NNP	B-NP	O
,	,	,	O	O
ZACK	ZACK	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NM201	NM201	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/18/06	1/18/06	CD	I-NP	O
@	@	SYM	B-NP	O
02	02	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

